Product Information

PRISTIQ ER 25 MG TABLET is a brand product labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., priced at $14.0020 per EA under NDC 00008121030. Its NADAC has been published 541 times since Nov 18, 2015.

The High Outlier badge above means this manufacturer's average price in the desvenlafaxine succinate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

PRISTIQ ER 25 MG TABLET

desvenlafaxine succinate
$14.0020per EA
High Outlier

Strength

25 mg/1

NDC

00008121030

Classification

Brand

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

DESVENLAFAXINE SUCCINATE

Approval Type

New Drug (NDA)

FDA Application

NDA021992

On Market Since

4/1/2015

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price Statistics

The NADAC for PRISTIQ ER 25 MG TABLET has been published 541 times since Nov 18, 2015, and over the history we have for it it has risen 88.1%. The table below summarizes its recorded NADAC range and movement.

Current price$14.0020 per EA
All-time high$14.0456 (Mar 15, 2023)
All-time low$7.4430 (Nov 18, 2015)
52-week high$14.0020
52-week low$13.9469
Median price$13.6363
Average price$12.7472
Largest weekly change+19.8% (Jan 6, 2016)
Weeks tracked541
Tracking sinceNov 18, 2015

Price History

1W

0.0%

1M

+0.3%

3M

+0.3%

6M

+0.2%

1Y

+0.1%

3Y

+0.1%

5Y

+2.7%

All

+88.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the desvenlafaxine succinate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of PRISTIQ ER 25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PRISTIQ ER 25 MG TABLET, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., is $14.0020 per EA (NDC 00008121030), effective Jun 24, 2026.

How has the price of PRISTIQ ER 25 MG TABLET changed over time?

Over the history we have for it, the NADAC for PRISTIQ ER 25 MG TABLET has risen 88.1%. It has been tracked across 541 weekly CMS publications since Nov 18, 2015.

What are the highest and lowest recorded NADAC prices for PRISTIQ ER 25 MG TABLET?

Since Nov 18, 2015, the NADAC for PRISTIQ ER 25 MG TABLET has ranged from a low of $7.4430 (Nov 18, 2015) to a high of $14.0456 (Mar 15, 2023), with a median of $13.6363 per EA.

Are there cheaper alternatives to PRISTIQ ER 25 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PRISTIQ ER 25 MG TABLET, so no direct lower-cost alternative is listed.

Who manufactures PRISTIQ ER 25 MG TABLET?

PRISTIQ ER 25 MG TABLET (NDC 00008121030) is labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., and CMS classifies it as a brand product.